Freve Jonathan
- SEC CIK
- 0001664466
No open-market purchases or sales filed in the past year.
Current role at each company
- DMRA Damora Therapeutics, Inc.Chief Financial Officeras of Jan 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Freve Jonathan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Freve JonathanChief Financial Officer | PPurchase | +4.00K | $2.49 | +$9.96K | +50.0%12.0K after | |
| Nov 9, 2021 (view filing) | Nov 8 | 1 day | Freve JonathanChief Financial Officer | PPurchase | +3.00K | $3.40 | +$10.2K | +60.0%8.00K after | |
| Aug 19, 2021 (view filing) | Aug 18 | 1 day | Freve JonathanChief Financial Officer | PPurchase | +3.00K | $3.92 | +$11.8K | +150.0%5.00K after |